Status:
COMPLETED
Viability of Pulsioflex Monitoring in ICU
Lead Sponsor:
University of Zurich
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
16+ years
Brief Summary
Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as go...
Detailed Description
Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as go...
Eligibility Criteria
Inclusion
- In situ pulmonary artery catheter
- Above 16 years of age
- At least 36 hours of continuous hemodynamic monitoring with the pulmonary artery catheter planed
Exclusion
- Patients with:
- Permanent or pesisting Atrial Fibrilation or Ventricular Arrythmias
- Moderate to Severe Aortic Insuficiency or Aortic Stenosis
- Intravascular Cardiac Assist Device
- Planed removal of the pulmonary artery catheter \<36 hours
Key Trial Info
Start Date :
July 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04911985
Start Date
July 1 2015
End Date
August 30 2019
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Medical intensive care unit
Zurich, Canton of Zurich, Switzerland, 8091